Riken Vitamin (4526) Latest Earnings: Operating Profit Decreased by 4.9% YoY to 2.248 Billion Yen, Net Income Up 2.4%

Riken Vitamin (4526) has released its latest financial results, reporting net sales of 25.133 billion yen, representing a +8.1% increase compared to the same period of the previous year. On the profit front, operating profit decreased by -4.9% YoY to 2.248 billion yen, while ordinary profit rose by +0.6% YoY to 2.547 billion yen, and net income attributable to owners of the parent grew by +2.4% YoY to 1.869 billion yen. Comprehensive income saw a significant expansion, surging +82.6% YoY to 3.096 billion yen.

From a financial and valuation perspective, the company maintains a solid equity ratio of 71.9%. Strong cash generation capabilities are highlighted by operating cash flow of 5.96 billion yen and free cash flow of 7.71 billion yen, alongside retained earnings of 68.67 billion yen. With cash and cash equivalents standing at a robust 19.13 billion yen, the company boasts a resilient financial foundation to support future business development and potential shareholder return strategies.